SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who wrote (544)5/6/1999 6:50:00 PM
From: DanZ  Read Replies (1) of 5582
 
Street Walker,

Thanks for your comments. You pointed out some important things that aren't obvious in the press release. I believe that GumTech management will still have much control over press releases from Gel Tech. With regard to allocation of revenue and expenses, if Gel Tech loses money, GumTech will account for the entire loss. As Gel Tech becomes profitable, the carryover loss will be reduced until it reaches zero. At that time, GumTech will book 60% of the profit from Gel Tech. You asked a good question about the capitalization of Gel Tech. I don't know how much money Biodelivery Technologies and GumTech contributed to start Gel Tech LLC. I'll look into this and post what I find out on this thread.

For those who don't regularly follow the GUMM thread on Yahoo, here is a link to my comments on the significance of today's agreement with Biodelivery Technologies.

messages.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News